BESORFIB Trademark

Trademark Overview

On Wednesday, December 29, 2010, a trademark application was filed for BESORFIB with the United States Patent and Trademark Office. The USPTO has given the BESORFIB trademark a serial number of 85207037. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 23, 2014. This trademark is owned by Warner-Lambert Company LLC. The BESORFIB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
besorfib

General Information

Serial Number85207037
Word MarkBESORFIB
Filing DateWednesday, December 29, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 23, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
Translation of Words in MarkThe wording "besorfib" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWarner-Lambert Company LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWarner-Lambert Company LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, June 23, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 23, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2013EXTENSION 5 GRANTED
Wednesday, October 30, 2013EXTENSION 5 FILED
Wednesday, October 30, 2013TEAS EXTENSION RECEIVED
Wednesday, May 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 21, 2013EXTENSION 4 GRANTED
Wednesday, May 15, 2013EXTENSION 4 FILED
Wednesday, May 15, 2013TEAS EXTENSION RECEIVED
Saturday, November 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 16, 2012EXTENSION 3 GRANTED
Wednesday, November 14, 2012EXTENSION 3 FILED
Wednesday, November 14, 2012TEAS EXTENSION RECEIVED
Monday, July 2, 2012ASSIGNED TO EXAMINER
Thursday, May 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 30, 2012EXTENSION 2 GRANTED
Friday, May 4, 2012EXTENSION 2 FILED
Thursday, May 24, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 4, 2012TEAS EXTENSION RECEIVED
Friday, November 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 9, 2011EXTENSION 1 GRANTED
Wednesday, November 9, 2011EXTENSION 1 FILED
Wednesday, November 9, 2011TEAS EXTENSION RECEIVED
Tuesday, May 17, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2011PUBLISHED FOR OPPOSITION
Thursday, February 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 17, 2011ASSIGNED TO LIE
Tuesday, February 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, February 15, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 15, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, February 15, 2011EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 15, 2011ASSIGNED TO EXAMINER
Wednesday, January 5, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 1, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

besorfib preparations pharmaceutical dysfunction treatment disorders erectile diseases urological urogenital sexual